Reply to: "Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization"
- PMID: 23046675
- DOI: 10.1016/j.jhep.2012.09.033
Reply to: "Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization"
Comment on
-
Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.J Hepatol. 2012 Jun;56(6):1336-42. doi: 10.1016/j.jhep.2012.01.006. Epub 2012 Feb 4. J Hepatol. 2012. PMID: 22314421 Clinical Trial.
-
Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization.J Hepatol. 2013 Jan;58(1):194. doi: 10.1016/j.jhep.2012.08.028. Epub 2012 Oct 6. J Hepatol. 2013. PMID: 23046673 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
